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Evidence for radiological and histopathological prognostic
importance of detecting extramural venous invasion in rectal
cancer: recommendations for radiology and histopathology
reporting
Introduction
Extramural venous invasion (EMVI) is widely regarded
as an adverse prognostic feature in rectal cancer. Whilst
the effect of venous invasion has been studied for more
than seven decades, Talbot’s study from St Mark’s Hos-
pital in 1980 was the first to specify the importance of
extramural vs intramural venous invasion and show that
it was only invasion of tumour into the extramural veins
that had a prognostic effect [1]. However, the current
literature is somewhat confusing, which is most proba-
bly due to heterogeneity of definitions. We discuss
some of the available evidence and offer guidance on
the optimal criteria for both histopathological and
radiological detection of EMVI within the context of
modern management of rectal cancer.
Prevalence
The true prevalence of histopathological EMVI in rectal
cancer is difficult to know and hinges on the rigour of
macroscopic and microscopic pathological evaluation,
and whether ancillary techniques have been used.
Reported detection rates have been inconsistent and the
incidence ranges from 9 to 61% [1–12]. Some series
have shown selection bias towards advanced cases which
may affect the true prevalence and result in a high
EMVI detection rate [13], whilst others do not differ-
entiate between rectal and colonic tumours. A more
recent challenge has been that the increasing use of pre-
operative radiotherapy has led to an inherent false-nega-
tive rate, resulting in under-reporting of venous
invasion due to obliteration of normal venous architec-
ture when involved veins are destroyed beyond recogni-
tion [14].
Histopathology-based detection
Optimal macroscopic examination
Rectal cancer resection specimens must be appropriately
opened, pinned out and fixed in formalin solution for
at least 48 h before dissection. Once adequately fixed,
the specimen should be cross-sectionally sliced trans-
versely at a thickness of 34 mm; these thin slices allow
identification of the depth of tumour invasion and sta-
tus of the circumferential resection margin. In addition,
serpiginous outgrowths of tumour extending beyond
and at right angles to the muscularis propria may be vis-
ible and probably represent a focus of EMVI (Fig. 1).
Areas for microscopic examination are then selected
with at least four sections of tumour taken targeting
areas of greatest interest. Evidence suggests that sec-
tions taken perpendicular to the tumour at the area of
maximal invasion are most likely to identify EMVI [15].
As many rectal tumours will have undergone neoadju-
vant radiotherapy, it may be difficult to identify areas of
residual tumour; in this instance a greater number of
blocks may be required concentrating on areas of fibro-
sis in the region of the irradiated tumour.
Optimal microscopic examination
The microscopic identification of EMVI relies upon the
identification of tumour cells within an endothelial or
smooth muscle-lined space containing red blood cells
outside the muscularis propria of the bowel wall as
defined in the UK Royal College of Pathologists
(RCPath) guidelines for reporting colorectal cancer
Figure 1 Gross pathology specimen showing tumour with
EMVI. Intravascular tumour deposits can be seen as serpigen-
ous extensions of tumour projecting from and at right angles
to the muscularis propria (see arrows).
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[16]. Due to the difficulties associated with tissue sec-
tioning and architectural distortion by tumour or fibro-
sis, vascular spaces may become difficult to identify on
routine haematoxylin and eosin (H&E) staining
(Fig. 2). As a result the rate of EMVI with H&E stain-
ing has been documented to be as low as 8% [17];
however, the RCPath guidelines suggest that EMVI
should be detected in at least 25% of cases of colorectal
cancer. There is no guidance as to the expected rate in
rectal cancers alone or those treated with neoadjuvant
radiotherapy; however, 25% may still be an underesti-
mate for the true prevalence of EMVI using an optimal
sampling technique. There is poor agreement, even
between specialist gastrointestinal histopathologists,
when identifying vascular invasion using H&E [18]. In
situations where uncertainty or disagreement exists as to
the nature of subserosal tumour deposits, the RCPath
guidelines recommend that deeper sections through the
tissue block should be performed to attempt to clarify
the nature of a lesion; alternatively special histochemical
and immunohistochemical stains can be invaluable
tools.
Special stains: histochemical staining
The elastic lamina within medium-to-large vessels pro-
vides a landmark, which can be highlighted by special
stains such as orcien and elastin Van Gieson (EVG); the
application of these stains has been shown to increase
the detection of EMVI from 19.6% to 58% [19]. Stain-
ing for the elastic lamina also improves agreement
between pathologists from poor to fair [18]. The only
significant drawback of these methods is that in selected
cases interpretation may be hampered by background
staining although this is rare.
Figure 2 Micrograph showing venous invasion as a linear
extension of tumour projecting beyond the muscularis propria
(see arrow). The vessel wall is largely destroyed by tumour and
an appreciation of the characteristic architecture is required to
accurately recognize this phenomenon.
(a)
(b)
(c)
(d)
(e)
Figure 3 Extramural venous invasion
demonstrated on H&E staining (a) and
confirmed using elastin Van Gieson (b),
and antibodies against smooth muscle
actin (c), CD34 (d) and CD31 (e). The
position of the tumour within the vessel
is highlighted by an arrow.
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Special stains: immunohistochemistry
Immunohistochemical stains using antibodies directed
towards endothelial (CD31 and CD34) or smooth
muscle (smooth muscle actin) antigens within vessel
walls also increase the sensitivity of histopathology-
detected EMVI. The potential advantage of these
methods is an increased specificity over histochemical
staining, although the endothelium may become lost
or obscured when a tumour embolus occupies a
vessel.
Kingston et al. examined the rate of detection when
using H&E, EVG and immunohistochemistry for
CD31 and CD34 in 50 cases of colorectal cancer in
which vascular invasion had previously not been identi-
fied; with the use of special stains they identified vascu-
lar invasion in 48% of cases [20]. Although this study
did not differentiate between intramural and extramural
vascular invasion, it showed that EVG was the most
sensitive method; however, in a minority of cases immu-
nohistochemical staining was still required. An example
of these histochemical and immunohistochemical stains
in practice is shown in Fig. 3a–e.
MRI-based detection
Optimal technique
High-resolution MRI is accurate in detecting EMVI
(mrEMVI) both before and after preoperative therapy.
Accurate detection is underpinned by strict adherence
to technique and image acquisition as well as a three-
dimensional understanding of the vascular anatomy sur-
rounding the rectum. Failure of the latter can confuse
venous invasion with nodal disease. Most scanners will
provide adequate 3 mm slices; however, optimal tech-
nique involves ensuring appropriate an field of view
(FOV) (16 9 16 cm) to obtain high-resolution images.
Incorrect FOV also results in loss of voxel size and ulti-
mately resolution. Furthermore, the field alignment
(a) (b)
(c) Figure 4 (a) MRI showing tumour
invasion into the superior rectal vein.
Dashed arrow indicates tumour
extension. Solid arrow shows signal void
in vessel which is surrounded by tumour.
(b) MRI showing tumour extending into
the middle rectal vein. The dashed arrow
shows signal void (black) shown in the
middle rectal vein; the solid arrow shows
tumour extension beyond the muscularis.
(c) MRI showing tumour in the inferior
rectal vein. There is signal void which
could be followed on sequential images
confirming this was the inferior rectal
vein.
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must be perpendicular to the long axis of the rectum or
vessels can be missed.
Characteristic radiological features of EMVI
Veins around the rectum are recognized on T2-
weighted images as serpiginous or tortuous linear struc-
tures which appear black due to the signal void of
blood. The larger ‘named’ vessels such as the superior
and middle rectal veins appear with anatomical consis-
tency, which helps in confident identification. Detection
of mrEMVI relies on the observation of intermediate
tumour signal disrupting the normal configuration of
the vessel resulting in irregular expansion of the vein,
loss of the signal void and intermediate signal intensity
which may or may not be contiguous with the main
tumour in the rectal wall [21]. Smaller venules can be
seen perforating the normal outer rectal wall and pro-
duce a low to intermediate signal intensity in tubular
structures on T2-weighted images  these are normal
vessels and should not be confused with mrEMVI [22].
Venous invasion into these smaller venules can be rec-
ognized by their expansion and irregularity adjacent to
the tumour due to contiguous tumour extension
(Fig. 4a–c).
Early studies showing correlation with histopathology
The first study to demonstrate the accuracy of MRI in
identifying the EMVI as a prognostic feature of rectal
cancer involved 98 patients with biopsy-proven rectal
cancer [23]. The prognostic significance of mrEMVI
has further been documented in a study by Smith et al.
[24]. They offered a scoring system based on previous
experience which identified particular morphological
and signal characteristics. Recurrence-free survival at
3 years was compared between MRI and histopathol-
ogy-detected EMVI and was reported as 35% and 34%,
respectively. Recurrence-free survival when EMVI was
not present was 73.8% and 74.1% respectively. A further
study using similar grading criteria reported mrEMVI in
42% of patients undergoing primary surgery for rectal
cancer. An mrEMVI score of 34 had 100% sensitivity
and 89% specificity in identifying EMVI involving veins
greater than 3 mm in diameter [25].
The potential of mrEMVI as an imaging biomarker
The prognostic effect of traditional adverse features has
not been prospectively validated in patients who have
undergone preoperative therapy. Perhaps those features
which we previously understood as having a significant
bearing on survival outcomes may not be as important
following chemoradiotherapy (CRT) providing optimal
surgery has taken place – such as nodal disease [26].
MRI is accurate in identifying EMVI following
chemoradiation providing the same diagnostic standard
is used [27,28]. Indeed, a comparison between the out-
comes of patients with mrEMVI and pathology-
detected EMVI showed that, not only is it associated
with poor disease-free survival when either technique is
used, but MRI identified more cases of EMVI than
pathology following CRT [29]. Further, a recent study
involving Stage II and Stage III patients who had
undergone preoperative long-course CRT showed that
evidence of EMVI led to significantly worse disease
recurrence and in fact Stage II tumours with EMVI had
similar outcomes to Stage III tumours [30]. mrEMVI
has also been shown to be a potential imaging biomar-
ker following neoadjuvant CRT. EMVI can be graded
following CRT using a regression grading score based
on the degree of radiological evidence of fibrosis shown
and this can be linked to survival outcomes. Patients
who demonstrated fibrosis of more than 50% in EMVI
had a 3-year disease-free survival of 87.9%. Where there
was less than 50% fibrosis disease-free survival was
45.8%. Fibrosis of less than 50% had a hazard ratio of
5.75 for disease recurrence [31].
Conclusion
There is now substantial evidence suggesting that EMVI
is an adverse prognostic feature in rectal cancer, includ-
ing in cases treated with neoadjuvant therapy. Whilst
special stains undoubtedly increase the reporting rates,
H&E staining unfortunately remains the gold standard
for most institutions. The use of special stains will
improve detection rates particularly following CRT and
must surely now be considered as routine in addition to
meticulous technique.
Furthermore, MRI can identify EMVI at the same
rate as histopathology and predicts the same outcome.
Using the radiological criteria described above will
allow for more consistent reporting of EMVI in the
preoperative setting. Multidisciplinary teams are urged
to regularly audit the reporting rates of EMVI using
both MRI and histopathology to ensure good concor-
dance.
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